« Go back to newsletter archive

Cologne, July 2016

Dear colleagues and friends,

Here are the latest news on the forthcoming 10ᵗʰ International Symposium on Hodgkin Lymphoma (ISHL10):

Satellite Program completed

We just completed the satellite program of ISHL10. There will be several highlights, such as latest clinical data with immune checkpoint inhibition and new drug combinations. Other topics include Hodgkin Lymphoma in young adults and the latest controversies on the best 1st line therapy.

Immunotherapy and checkpoint inhibition were also highlighted at the European EHA21 Symposium!

The symposium will take place in Cologne, Germany, between October 22 and 25, 2016. Time to register.

For more information, please go to hodgkinsymposium.org or contact our organizational team directly at info@hodgkinsymposium.org.

Best wishes

Andreas Engert, MD, Congress and GHSG Chairman

Boris Böll, MD, Congress Secretary

Bastian von Tresckow, MD, Congress Secretary


Please do not reply directly to this message. If you would like more information on the 10ᵗʰ International Symposium on Hogkin Lymphoma, or have additional questions please contact Gabriele Hanke (info@hodgkinsymposium.org).

Please add enews@hodgkinsymposium.org to your address book to prevent spam filters from blocking these e-mails.

10ᵗʰ International Symposium on Hodgkin Lymphoma
Prof. Dr. Andreas Engert | Klinik I für Innere Medizin
Klinikum der Universität zu Köln | Kerpener Str. 62 | D-50924 Köln

Tel. +49 (0)221-478 5933
Fax +49 (0)221-478 3778

E-Mail: info@hodgkinsymposium.org

Legal Entity: The University Hospital of Cologne is a Public Law Institution.

For more information please click here .